Takeda Pharmaceutical reported total assets of $98.27B and total liabilities of $50.85B for the quarter ended Jun 2026, up 1.5% year over year. This balance sheet covers 32 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Nov2019 | Mar2020 | Jun2020 | Dec2020 | Mar2021 | Jun2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 9.13B | 5.98B | 7.31B | 6.57B | 6.15B | 6.01B | 4.03B | 2.31B | 3.69B | 1.95B | 3.09B | 5.17B | 5.76B | 3.25B | 2.52B | 2.42B | 4.63B | 4.26B | 3.79B | 2.89B | ||||||||||||
| Short-term InvestmentsInvestments (Current) | 2.23B | 2.37B | 2.01B | 2.20B | 2.38B | 1.95B | 2.11B | 2.14B | 2.17B | 1.82B | 2.30B | 2.31B | 1.75B | 2.61B | 2.30B | 2.33B | 2.48B | 2.75B | 2.81B | 2.91B | ||||||||||||
| Cash & Current Investments | 11.36B | 8.35B | 9.32B | 8.77B | 8.53B | 7.96B | 6.15B | 4.45B | 5.86B | 3.77B | 5.39B | 7.48B | 7.51B | 5.87B | 4.83B | 4.75B | 7.11B | 7.01B | 6.60B | 5.80B | ||||||||||||
| Receivables - NetNet Receivables | 7.45B | 7.56B | 6.11B | 5.89B | 5.50B | 5.01B | 5.10B | 5.79B | 5.23B | 4.85B | 4.85B | 4.85B | 4.70B | 4.68B | 5.05B | 4.60B | 4.68B | 4.79B | 5.38B | 5.84B | ||||||||||||
| Receivables | 7.45B | 7.56B | 6.11B | 5.89B | 5.50B | 5.01B | 5.10B | 5.79B | 5.23B | 4.85B | 4.85B | 4.85B | 4.70B | 4.68B | 5.05B | 4.60B | 4.68B | 4.79B | 5.38B | 5.84B | ||||||||||||
| Raw Materials | ||||||||||||||||||||||||||||||||
| Work In Process | ||||||||||||||||||||||||||||||||
| Inventory | 7.12B | 7.12B | 7.34B | 7.17B | 6.90B | 6.56B | 7.46B | 7.91B | 8.00B | 7.91B | 8.16B | 8.20B | 8.09B | 8.20B | 7.98B | 8.57B | 8.82B | 9.14B | 8.91B | 9.08B | ||||||||||||
| Prepaid Assets | 1.16B | 1.22B | 1.21B | 1.26B | 1.13B | 1.10B | 1.22B | 1.31B | 1.23B | 1.21B | 1.14B | 1.27B | 1.08B | 1.18B | 1.05B | 1.20B | 1.13B | 1.14B | 1.04B | 1.18B | ||||||||||||
| Current Assets | 25.63B | 22.62B | 22.32B | 19.71B | 19.88B | 18.37B | 18.13B | 18.04B | 17.05B | 16.43B | 17.26B | 19.96B | 20.47B | 18.12B | 16.53B | 17.37B | 19.82B | 20.25B | 19.71B | 19.76B | ||||||||||||
| Non-Current Assets | ||||||||||||||||||||||||||||||||
| Buildings | ||||||||||||||||||||||||||||||||
| Construction in Progress | ||||||||||||||||||||||||||||||||
| Land & Improvements | ||||||||||||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 13.74B | 13.27B | 13.62B | 13.19B | 12.75B | 11.72B | 12.79B | 13.10B | 13.12B | 12.46B | 13.43B | 13.40B | 12.65B | 13.27B | 12.90B | 13.52B | 13.47B | 13.54B | 13.52B | 13.44B | ||||||||||||
| Long-Term Investments | 1.06B | 1.06B | 0.83B | 0.75B | 0.70B | 0.67B | 0.75B | 0.73B | 0.71B | 0.70B | 0.61B | 0.56B | 0.10B | 0.08B | 0.07B | 0.07B | 0.06B | 0.07B | 0.06B | 0.06B | ||||||||||||
| Goodwill | 38.11B | 37.08B | 37.93B | 37.22B | 36.16B | 33.20B | 36.22B | 37.81B | 36.71B | 34.58B | 36.51B | 36.83B | 34.59B | 36.32B | 34.90B | 36.60B | 36.86B | 37.38B | 37.04B | 36.93B | ||||||||||||
| Intangibles | 36.93B | 35.23B | 32.86B | 32.05B | 30.32B | 26.66B | 32.28B | 32.94B | 30.48B | 27.72B | 28.84B | 28.05B | 25.28B | 26.00B | 23.80B | 23.65B | 22.39B | 22.84B | 21.80B | 21.28B | ||||||||||||
| Goodwill & Intangibles | 75.04B | 72.31B | 70.79B | 69.27B | 66.48B | 59.86B | 68.50B | 70.75B | 67.19B | 62.30B | 65.35B | 64.88B | 59.87B | 62.32B | 58.70B | 60.25B | 59.25B | 60.23B | 58.85B | 58.21B | ||||||||||||
| Long-Term Deferred Tax | 3.34B | 3.14B | 3.12B | 2.98B | 2.86B | 2.54B | 2.77B | 2.74B | 2.33B | 2.14B | 2.66B | 2.45B | 2.27B | 2.47B | 2.43B | 2.77B | 2.65B | 2.78B | 3.48B | 3.38B | ||||||||||||
| Other Non-Current Assets | 0.95B | 0.87B | 0.71B | 0.65B | 0.58B | 0.47B | 0.48B | 0.44B | 0.41B | 0.37B | 0.35B | 0.68B | 0.57B | 0.49B | 0.46B | 0.47B | 0.48B | 0.51B | 0.49B | 0.50B | ||||||||||||
| Non-Current Assets | 96.36B | 93.00B | 91.08B | 89.05B | 85.75B | 77.22B | 87.39B | 89.90B | 85.93B | 79.79B | 84.69B | 84.28B | 77.22B | 81.25B | 76.87B | 79.42B | 78.38B | 79.87B | 79.20B | 78.51B | ||||||||||||
| Assets | 121.99B | 115.62B | 113.39B | 108.76B | 105.63B | 95.59B | 105.52B | 107.94B | 102.98B | 96.22B | 101.95B | 104.25B | 97.70B | 99.37B | 93.39B | 96.79B | 98.21B | 100.12B | 98.91B | 98.27B | ||||||||||||
| Liabilities | ||||||||||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||||||||||
| Accounts Payables | 3.25B | 2.93B | 4.44B | 3.28B | 2.81B | 2.70B | 4.91B | 3.22B | 2.92B | 3.27B | 3.69B | 3.01B | 2.77B | 3.03B | 3.12B | 2.91B | 2.98B | 3.04B | 3.13B | 2.80B | ||||||||||||
| Notes Payables | ||||||||||||||||||||||||||||||||
| Payables | 3.25B | 2.93B | 4.44B | 3.28B | 2.81B | 2.70B | 4.91B | 3.22B | 2.92B | 3.27B | 3.69B | 3.01B | 2.77B | 3.03B | 3.12B | 2.91B | 2.98B | 3.04B | 3.13B | 2.80B | ||||||||||||
| Accumulated Expenses | ||||||||||||||||||||||||||||||||
| Other Accumulated Expenses | 5.13B | 4.73B | 5.03B | 4.69B | 4.68B | 4.53B | 4.28B | 4.08B | 3.99B | 3.96B | 4.18B | 3.63B | 3.35B | 3.72B | 3.91B | 3.57B | 3.43B | 3.69B | 3.76B | 3.59B | ||||||||||||
| Short term Debt | 2.34B | 2.13B | 1.69B | 1.08B | 0.82B | 1.28B | 1.40B | 2.29B | 2.13B | 1.68B | 0.97B | 1.70B | 1.36B | 1.42B | 1.44B | 1.42B | 1.53B | 1.76B | 0.90B | 0.69B | ||||||||||||
| Current Leases | ||||||||||||||||||||||||||||||||
| Current Taxes | 0.32B | 0.26B | 0.19B | 0.21B | 0.20B | 0.18B | 0.19B | 0.04B | 0.03B | 0.03B | 0.03B | 1.04B | 0.95B | 0.00B | 0.88B | 0.00B | 0.02B | 0.02B | 0.62B | 0.74B | ||||||||||||
| Current Deferred Revenue | ||||||||||||||||||||||||||||||||
| Curent Deferred Tax LiabilityCurent Deferred Tax | ||||||||||||||||||||||||||||||||
| Total Current Liabilities | 16.75B | 15.59B | 18.46B | 16.76B | 17.32B | 15.83B | 18.76B | 18.26B | 16.39B | 15.44B | 15.61B | 15.84B | 16.00B | 13.80B | 16.43B | 14.99B | 14.52B | 16.96B | 18.06B | 17.34B | ||||||||||||
| Non-Current Liabilities | ||||||||||||||||||||||||||||||||
| Capital Leases | ||||||||||||||||||||||||||||||||
| Non-Current Debt | 43.58B | 35.64B | 30.56B | 30.21B | 26.00B | 27.86B | ||||||||||||||||||||||||||
| Convertible Debt | 0.37B | 0.33B | 0.45B | 0.44B | 0.49B | 0.42B | 0.42B | 0.43B | 0.10B | 0.09B | 0.10B | 0.08B | 0.10B | 0.17B | 0.23B | 0.24B | 0.22B | 0.22B | 0.24B | 0.24B | ||||||||||||
| Pension | 1.50B | 1.47B | 1.25B | 1.08B | 0.99B | 0.94B | 0.96B | 1.00B | 0.93B | 0.94B | 0.97B | 0.96B | 0.91B | 0.94B | 0.89B | 0.98B | 0.98B | 0.98B | 0.92B | 0.89B | ||||||||||||
| Minority Interest | 0.04B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | 0.01B | |||||||||||||
| Liabilities from Discontinued OperationsLiabilities from Discont. Ops | 0.01B | 0.01B | 0.00B | 0.01B | 0.01B | 0.00B | 0.01B | 0.01B | 0.01B | |||||||||||||||||||||||
| Non-Current Deferred Tax LiabilityNon-Current Deferred Tax | 5.13B | 5.02B | 3.89B | 3.53B | 3.37B | 2.75B | 2.05B | 1.97B | 1.58B | 0.90B | 0.77B | 0.36B | 0.31B | 0.25B | 0.23B | 0.23B | 0.22B | 0.20B | 0.17B | 0.17B | ||||||||||||
| Operating Leases | ||||||||||||||||||||||||||||||||
| Other Non-Current Liabilities | 0.54B | 0.54B | 0.58B | 0.56B | 0.51B | 0.47B | 0.49B | 0.53B | 0.49B | 0.49B | 0.55B | 0.56B | 0.54B | 0.57B | 0.54B | 0.62B | 0.61B | 0.63B | 0.64B | 0.73B | ||||||||||||
| Total Non-Current Liabilities | 56.33B | 52.18B | 46.03B | 43.16B | 39.70B | 36.04B | 38.72B | 39.18B | 37.62B | 35.17B | 37.26B | 38.31B | 35.29B | 36.77B | 31.50B | 34.34B | 35.28B | 33.49B | 33.47B | 33.50B | ||||||||||||
| Total Liabilities | 73.08B | 67.21B | 64.47B | 59.91B | 57.02B | 51.87B | 57.48B | 57.43B | 54.02B | 50.61B | 52.87B | 54.14B | 50.57B | 47.93B | 49.33B | 49.81B | 50.45B | 51.53B | 50.85B | |||||||||||||
| Shareholder's Equity | ||||||||||||||||||||||||||||||||
| Total Debt | 45.93B | 2.13B | 37.32B | 1.08B | 0.82B | 1.28B | 31.97B | 2.29B | 2.13B | 1.68B | 31.17B | 1.70B | 1.36B | 1.42B | 27.43B | 1.42B | 1.53B | 1.76B | 28.76B | 0.69B | ||||||||||||
| Common Equity | 48.91B | 48.42B | 48.92B | 48.85B | 48.61B | 43.72B | 48.04B | 50.51B | 48.96B | 45.62B | 49.08B | 50.10B | 48.80B | 45.46B | 47.45B | 48.40B | 49.67B | 47.38B | 47.42B | |||||||||||||
| Liabilities and Shareholders Equity | 121.99B | 115.62B | 113.39B | 108.76B | 105.63B | 95.59B | 105.52B | 107.94B | 102.98B | 96.22B | 101.95B | 104.25B | 97.70B | 99.37B | 93.39B | 96.79B | 98.21B | 100.12B | 98.91B | 98.27B | ||||||||||||
| Treasury Shares | 0.00B | -0.02B | 0.00B | -0.21B | -0.19B | -0.19B | -0.20B | -0.02B | -0.02B | -0.02B | -0.02B | -0.01B | -0.34B | -0.35B | -0.33B | |||||||||||||||||
| Retained Earnings | 14.26B | 14.31B | 12.73B | 11.29B | 11.08B | 10.67B | 11.65B | 10.87B | 10.01B | 9.45B | 9.39B | 8.60B | 8.49B | 7.78B | 7.99B | 7.80B | 7.12B | 4.54B | 4.18B | |||||||||||||
| Preferred Shares |
Pull Takeda Pharmaceutical's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=TAK&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "TAK", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=TAK&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();